Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jul;8(3):406–410. doi: 10.1128/cmr.8.3.406

Nucleic acid vaccines.

F R Vogel 1, N Sarver 1
PMCID: PMC174632  PMID: 7553573

Abstract

The use of nucleic acid-based vaccines is a novel approach to immunization that elicits immune responses similar to those induced by live, attenuated vaccines. Administration of nucleic acid vaccines results in the endogenous generation of viral proteins with native conformation, glycosylation profiles, and other posttranslational modifications that mimic antigen produced during natural viral infection. Nucleic acid vaccines have been shown to elicit both antibody and cytotoxic T-lymphocyte responses to diverse protein antigens. Advantages of nucleic acid-based vaccines include the simplicity of the vector, the ease of delivery, the duration of expression, and, to date, the lack of evidence of integration. Further studies are needed to assess the feasibility, safety, and efficacy of this new and promising technology.

Full Text

The Full Text of this article is available as a PDF (184.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chada S., DeJesus C. E., Townsend K., Lee W. T., Laube L., Jolly D. J., Chang S. M., Warner J. F. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes. J Virol. 1993 Jun;67(6):3409–3417. doi: 10.1128/jvi.67.6.3409-3417.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cheng L., Ziegelhoffer P. R., Yang N. S. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4455–4459. doi: 10.1073/pnas.90.10.4455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cox G. J., Zamb T. J., Babiuk L. A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993 Sep;67(9):5664–5667. doi: 10.1128/jvi.67.9.5664-5667.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 1992 Dec 18;258(5090):1938–1941. doi: 10.1126/science.1470917. [DOI] [PubMed] [Google Scholar]
  5. Davis H. L., Demeneix B. A., Quantin B., Coulombe J., Whalen R. G. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther. 1993 Dec;4(6):733–740. doi: 10.1089/hum.1993.4.6-733. [DOI] [PubMed] [Google Scholar]
  6. Davis H. L., Michel M. L., Whalen R. G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet. 1993 Nov;2(11):1847–1851. doi: 10.1093/hmg/2.11.1847. [DOI] [PubMed] [Google Scholar]
  7. Davis H. L., Whalen R. G., Demeneix B. A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther. 1993 Apr;4(2):151–159. doi: 10.1089/hum.1993.4.2-151. [DOI] [PubMed] [Google Scholar]
  8. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11478–11482. doi: 10.1073/pnas.90.24.11478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 1993;11:403–450. doi: 10.1146/annurev.iy.11.040193.002155. [DOI] [PubMed] [Google Scholar]
  10. Hoffman S. L., Sedegah M., Hedstrom R. C. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine. 1994 Dec;12(16):1529–1533. doi: 10.1016/0264-410x(94)90078-7. [DOI] [PubMed] [Google Scholar]
  11. Irwin M. J., Laube L. S., Lee V., Austin M., Chada S., Anderson C. G., Townsend K., Jolly D. J., Warner J. F. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J Virol. 1994 Aug;68(8):5036–5044. doi: 10.1128/jvi.68.8.5036-5044.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Israel Z. R., Edmonson P. F., Maul D. H., O'Neil S. P., Mossman S. P., Thiriart C., Fabry L., Van Opstal O., Bruck C., Bex F. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol. 1994 Mar;68(3):1843–1853. doi: 10.1128/jvi.68.3.1843-1853.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jiao S., Williams P., Berg R. K., Hodgeman B. A., Liu L., Repetto G., Wolff J. A. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther. 1992 Feb;3(1):21–33. doi: 10.1089/hum.1992.3.1-21. [DOI] [PubMed] [Google Scholar]
  14. Lowrie D. B., Tascon R. E., Colston M. J., Silva C. L. Towards a DNA vaccine against tuberculosis. Vaccine. 1994 Dec;12(16):1537–1540. doi: 10.1016/0264-410x(94)90080-9. [DOI] [PubMed] [Google Scholar]
  15. Madaio M. P., Hodder S., Schwartz R. S., Stollar B. D. Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol. 1984 Feb;132(2):872–876. [PubMed] [Google Scholar]
  16. Martinon F., Krishnan S., Lenzen G., Magné R., Gomard E., Guillet J. G., Lévy J. P., Meulien P. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol. 1993 Jul;23(7):1719–1722. doi: 10.1002/eji.1830230749. [DOI] [PubMed] [Google Scholar]
  17. Montgomery D. L., Shiver J. W., Leander K. R., Perry H. C., Friedman A., Martinez D., Ulmer J. B., Donnelly J. J., Liu M. A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 1993 Nov;12(9):777–783. doi: 10.1089/dna.1993.12.777. [DOI] [PubMed] [Google Scholar]
  18. Robinson H. L., Hunt L. A., Webster R. G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 1993;11(9):957–960. doi: 10.1016/0264-410x(93)90385-b. [DOI] [PubMed] [Google Scholar]
  19. Smith H. A. Regulatory considerations for nucleic acid vaccines. Vaccine. 1994 Dec;12(16):1515–1519. doi: 10.1016/0264-410x(94)90075-2. [DOI] [PubMed] [Google Scholar]
  20. Tang D. C., DeVit M., Johnston S. A. Genetic immunization is a simple method for eliciting an immune response. Nature. 1992 Mar 12;356(6365):152–154. doi: 10.1038/356152a0. [DOI] [PubMed] [Google Scholar]
  21. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993 Mar 19;259(5102):1745–1749. doi: 10.1126/science.8456302. [DOI] [PubMed] [Google Scholar]
  22. Wang B., Boyer J., Srikantan V., Coney L., Carrano R., Phan C., Merva M., Dang K., Agadjanan M., Gilbert L. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 1993 Nov;12(9):799–805. doi: 10.1089/dna.1993.12.799. [DOI] [PubMed] [Google Scholar]
  23. Wang B., Ugen K. E., Srikantan V., Agadjanyan M. G., Dang K., Refaeli Y., Sato A. I., Boyer J., Williams W. V., Weiner D. B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4156–4160. doi: 10.1073/pnas.90.9.4156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Webster R. G., Fynan E. F., Santoro J. C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine. 1994 Dec;12(16):1495–1498. doi: 10.1016/0264-410x(94)90071-x. [DOI] [PubMed] [Google Scholar]
  25. Williams R. S., Johnston S. A., Riedy M., DeVit M. J., McElligott S. G., Sanford J. C. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2726–2730. doi: 10.1073/pnas.88.7.2726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wolff J. A., Ludtke J. J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet. 1992 Sep;1(6):363–369. doi: 10.1093/hmg/1.6.363. [DOI] [PubMed] [Google Scholar]
  27. Wolff J. A., Malone R. W., Williams P., Chong W., Acsadi G., Jani A., Felgner P. L. Direct gene transfer into mouse muscle in vivo. Science. 1990 Mar 23;247(4949 Pt 1):1465–1468. doi: 10.1126/science.1690918. [DOI] [PubMed] [Google Scholar]
  28. Xu D., Liew F. Y. Genetic vaccination against leishmaniasis. Vaccine. 1994 Dec;12(16):1534–1536. doi: 10.1016/0264-410x(94)90079-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES